203 related articles for article (PubMed ID: 17672898)
21. p16INK4a polymorphism: associations with tumour progression in patients with sporadic colorectal cancer.
McCloud JM; Sivakumar R; Greenhough A; Elder J; Jones PW; Deakin M; Elder JB; Fryer AA; Hoban PR
Int J Oncol; 2004 Nov; 25(5):1447-52. PubMed ID: 15492837
[TBL] [Abstract][Full Text] [Related]
22. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
[TBL] [Abstract][Full Text] [Related]
23. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
24. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
26. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
[TBL] [Abstract][Full Text] [Related]
27. Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity.
Chen D; Song S; Lu J; Luo Y; Yang Z; Huang Q; Fu X; Fan X; Wei Y; Wang J; Wang L
Carcinogenesis; 2011 Jul; 32(7):1043-9. PubMed ID: 21393476
[TBL] [Abstract][Full Text] [Related]
28. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
29. Eotaxin-2 and colorectal cancer: a potential target for immune therapy.
Cheadle EJ; Riyad K; Subar D; Rothwell DG; Ashton G; Batha H; Sherlock DJ; Hawkins RE; Gilham DE
Clin Cancer Res; 2007 Oct; 13(19):5719-28. PubMed ID: 17908961
[TBL] [Abstract][Full Text] [Related]
30. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.
Belluco C; Olivieri F; Bonafè M; Giovagnetti S; Mammano E; Scalerta R; Ambrosi A; Franceschi C; Nitti D; Lise M
Clin Cancer Res; 2003 Jun; 9(6):2173-6. PubMed ID: 12796383
[TBL] [Abstract][Full Text] [Related]
31. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
32. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer.
Albrethsen J; Møller CH; Olsen J; Raskov H; Gammeltoft S
Eur J Cancer; 2006 Nov; 42(17):3057-64. PubMed ID: 17015013
[TBL] [Abstract][Full Text] [Related]
33. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
[TBL] [Abstract][Full Text] [Related]
34. Variant eotaxin: its effects on the asthma phenotype.
Nakamura H; Luster AD; Nakamura T; In KH; Sonna LA; Deykin A; Israel E; Drazen JM; Lilly CM
J Allergy Clin Immunol; 2001 Dec; 108(6):946-53. PubMed ID: 11742272
[TBL] [Abstract][Full Text] [Related]
35. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
36. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
37. Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas.
Wågsäter D; Dimberg J
Anticancer Res; 2004; 24(6):3711-4. PubMed ID: 15736401
[TBL] [Abstract][Full Text] [Related]
38. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
Kinugasa T; Huo Q; Higashi D; Shibaguchi H; Kuroki M; Tanaka T; Futami K; Yamashita Y; Hachimine K; Maekawa S; Nabeshima K; Iwasaki H; Kuroki M
Anticancer Res; 2007; 27(6A):3729-34. PubMed ID: 17970035
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
40. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
